ChemScene

ChemScene logo

Imagine the power of people with a common purpose to build relationships that create value for you and your business. This is ChemScene. Every day, our people work with you to ensure you have what you need to achieve your commercial and scientific pursuits. We make sure everything we do honors that relationship starting from our commitment to ensuring that our chemicals are held to the most rigorous quality standards in the world, to the way we engage with our customers and communities to do business responsibly.

Company Website

Product Listing

(+)-JQ1 PA 100mg  | ≥98%

ChemScene

(+)-JQ1 PA is a derivative of the Bromodomain and extra-terminal (BET) inhibitor JQ1, with an IC50 of 10.4 nM. IC50 & Target: 10.4 nM (BET)[1]. In Vitro: (+)-JQ1 PA is a derivative of JQ1, which is the inhibitor of BET. The IC50 of (+)-JQ1 PA for BET is 10.4 nM, and the IC50 of JQ1 […]

More Information Supplier Page

(+)-JQ1 PA 5mg  | ≥98%

ChemScene

(+)-JQ1 PA is a derivative of the Bromodomain and extra-terminal (BET) inhibitor JQ1, with an IC50 of 10.4 nM. IC50 & Target: 10.4 nM (BET)[1]. In Vitro: (+)-JQ1 PA is a derivative of JQ1, which is the inhibitor of BET. The IC50 of (+)-JQ1 PA for BET is 10.4 nM, and the IC50 of JQ1 […]

More Information Supplier Page

(+)-JQ1 PA 10mg  | ≥98%

ChemScene

(+)-JQ1 PA is a derivative of the Bromodomain and extra-terminal (BET) inhibitor JQ1, with an IC50 of 10.4 nM. IC50 & Target: 10.4 nM (BET)[1]. In Vitro: (+)-JQ1 PA is a derivative of JQ1, which is the inhibitor of BET. The IC50 of (+)-JQ1 PA for BET is 10.4 nM, and the IC50 of JQ1 […]

More Information Supplier Page

(+)-JQ1 PA 25mg  | ≥98%

ChemScene

(+)-JQ1 PA is a derivative of the Bromodomain and extra-terminal (BET) inhibitor JQ1, with an IC50 of 10.4 nM. IC50 & Target: 10.4 nM (BET)[1]. In Vitro: (+)-JQ1 PA is a derivative of JQ1, which is the inhibitor of BET. The IC50 of (+)-JQ1 PA for BET is 10.4 nM, and the IC50 of JQ1 […]

More Information Supplier Page

(+)-JQ1 PA 50mg  | ≥98%

ChemScene

(+)-JQ1 PA is a derivative of the Bromodomain and extra-terminal (BET) inhibitor JQ1, with an IC50 of 10.4 nM. IC50 & Target: 10.4 nM (BET)[1]. In Vitro: (+)-JQ1 PA is a derivative of JQ1, which is the inhibitor of BET. The IC50 of (+)-JQ1 PA for BET is 10.4 nM, and the IC50 of JQ1 […]

More Information Supplier Page

(+)-Kavain 10mg  | ≥98%

ChemScene

(+)-Kavain, a main kavalactone extracted from Piper methysticum, has anticonvulsive properties, attenuating vascular smooth muscle contraction through interactions with voltage-dependent Na+ and Ca2+ channels[1]. (+)-Kavain is shown to bind at the α4β2δ GABAA receptor and potentiate GABA efficacy[2]. (+)-Kavain is used as a treatment for inflammatory diseases, its anti-inflammatory action has been widely studied[4]. IC50 […]

More Information Supplier Page

(+)-Kavain 5mg  | ≥98%

ChemScene

(+)-Kavain, a main kavalactone extracted from Piper methysticum, has anticonvulsive properties, attenuating vascular smooth muscle contraction through interactions with voltage-dependent Na+ and Ca2+ channels[1]. (+)-Kavain is shown to bind at the α4β2δ GABAA receptor and potentiate GABA efficacy[2]. (+)-Kavain is used as a treatment for inflammatory diseases, its anti-inflammatory action has been widely studied[4]. IC50 […]

More Information Supplier Page

(+)-PD 128907 hydrochloride 5mg  | ≥98%

ChemScene

(+)-PD 128907 hydrochloride is a selective dopamine D2/D3 receptor agonist, with Kis of 1.7, 0.84 nM for human and rat D3 receptors, 179, 770 n M for human and rat D3 receptors, respectively. IC50 & Target: Ki: 1.7 nM (human D3 receptor), 0.84 nM (rat D3 receptor), 179 nM (human D2 receptor), 770 nM (rat […]

More Information Supplier Page

(+)-PD 128907 hydrochloride 10mg  | ≥98%

ChemScene

(+)-PD 128907 hydrochloride is a selective dopamine D2/D3 receptor agonist, with Kis of 1.7, 0.84 nM for human and rat D3 receptors, 179, 770 n M for human and rat D3 receptors, respectively. IC50 & Target: Ki: 1.7 nM (human D3 receptor), 0.84 nM (rat D3 receptor), 179 nM (human D2 receptor), 770 nM (rat […]

More Information Supplier Page

(+)-PD 128907 hydrochloride 25mg  | ≥98%

ChemScene

(+)-PD 128907 hydrochloride is a selective dopamine D2/D3 receptor agonist, with Kis of 1.7, 0.84 nM for human and rat D3 receptors, 179, 770 n M for human and rat D3 receptors, respectively. IC50 & Target: Ki: 1.7 nM (human D3 receptor), 0.84 nM (rat D3 receptor), 179 nM (human D2 receptor), 770 nM (rat […]

More Information Supplier Page

(+)-PD 128907 hydrochloride 50mg  | ≥98%

ChemScene

(+)-PD 128907 hydrochloride is a selective dopamine D2/D3 receptor agonist, with Kis of 1.7, 0.84 nM for human and rat D3 receptors, 179, 770 n M for human and rat D3 receptors, respectively. IC50 & Target: Ki: 1.7 nM (human D3 receptor), 0.84 nM (rat D3 receptor), 179 nM (human D2 receptor), 770 nM (rat […]

More Information Supplier Page

(+)-Penbutolol 5mg  | ≥98%

ChemScene

(+)-Penbutolol is a β-adrenoceptor antagonist, with an IC50 of 0.74 μM[1]. (+)-Penbutolol is an optical isomer of l-penbutolol with Na+ channel-blocking action[2]. IC50 & Target: IC50: 0.74 μM (β-adrenoceptor)[1]. In Vitro: (+)-penbutolol on the [Ca2+]i-increase induced by LPC is concentration-dependent[1]. (+)-penbutolol inhibits the rounding of cells dose dependently (8±4%, 56±4% and 66±2% at the concentrations […]

More Information Supplier Page

(+)-Penbutolol 10mg  | ≥98%

ChemScene

(+)-Penbutolol is a β-adrenoceptor antagonist, with an IC50 of 0.74 μM[1]. (+)-Penbutolol is an optical isomer of l-penbutolol with Na+ channel-blocking action[2]. IC50 & Target: IC50: 0.74 μM (β-adrenoceptor)[1]. In Vitro: (+)-penbutolol on the [Ca2+]i-increase induced by LPC is concentration-dependent[1]. (+)-penbutolol inhibits the rounding of cells dose dependently (8±4%, 56±4% and 66±2% at the concentrations […]

More Information Supplier Page

(+)-Penbutolol 50mg  | ≥98%

ChemScene

(+)-Penbutolol is a β-adrenoceptor antagonist, with an IC50 of 0.74 μM[1]. (+)-Penbutolol is an optical isomer of l-penbutolol with Na+ channel-blocking action[2]. IC50 & Target: IC50: 0.74 μM (β-adrenoceptor)[1]. In Vitro: (+)-penbutolol on the [Ca2+]i-increase induced by LPC is concentration-dependent[1]. (+)-penbutolol inhibits the rounding of cells dose dependently (8±4%, 56±4% and 66±2% at the concentrations […]

More Information Supplier Page

(+)-Penbutolol 100mg  | ≥98%

ChemScene

(+)-Penbutolol is a β-adrenoceptor antagonist, with an IC50 of 0.74 μM[1]. (+)-Penbutolol is an optical isomer of l-penbutolol with Na+ channel-blocking action[2]. IC50 & Target: IC50: 0.74 μM (β-adrenoceptor)[1]. In Vitro: (+)-penbutolol on the [Ca2+]i-increase induced by LPC is concentration-dependent[1]. (+)-penbutolol inhibits the rounding of cells dose dependently (8±4%, 56±4% and 66±2% at the concentrations […]

More Information Supplier Page

(+)-Sparteine 5g  | ≥98%

ChemScene

(+)-Sparteine is a natural alkaloid acting as a ganglionic blocking agent. (+)-Sparteine competitively blocks nicotinic ACh receptor in the neurons. IC50 & Target: AChR[1] In Vitro: (+)-Sparteine (2 μM) reduces the ACh-induced current caused by activation of nicotinic AChRs in a voltage-independent manner. (+)-Sparteine (5, 10 μM) reduces the amplitude of the excitatory postsynaptic current […]

More Information Supplier Page

(+)-Sparteine 10g  | ≥98%

ChemScene

(+)-Sparteine is a natural alkaloid acting as a ganglionic blocking agent. (+)-Sparteine competitively blocks nicotinic ACh receptor in the neurons. IC50 & Target: AChR[1] In Vitro: (+)-Sparteine (2 μM) reduces the ACh-induced current caused by activation of nicotinic AChRs in a voltage-independent manner. (+)-Sparteine (5, 10 μM) reduces the amplitude of the excitatory postsynaptic current […]

More Information Supplier Page

(+)-Sparteine 25g  | ≥98%

ChemScene

(+)-Sparteine is a natural alkaloid acting as a ganglionic blocking agent. (+)-Sparteine competitively blocks nicotinic ACh receptor in the neurons. IC50 & Target: AChR[1] In Vitro: (+)-Sparteine (2 μM) reduces the ACh-induced current caused by activation of nicotinic AChRs in a voltage-independent manner. (+)-Sparteine (5, 10 μM) reduces the amplitude of the excitatory postsynaptic current […]

More Information Supplier Page